LALesley Allison

Lesley Allison

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lesley Allison has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Concurrent outbreaks of Escherichia coli O157:H7 and O157:H39 with high asymptomatic carriage of other Shiga toxin-producing E. coli in nursery children, south-east Scotland, United Kingdom, July to October 2022

    by Amir Kirolos, Marion Muir, Andrew Douglas, Genna Leckenby, Lesley Allison, Graham Mackenzie, on behalf of the Incident Management Team

    We managed a complex outbreak of Shiga toxin-producing Escherichia coli (STEC) and stx -negative E. coli O157 (non-STEC) cases in four nurseries in two neighbouring towns in south-east Scotland, with epidemiological links through shared management, staff or other visits. There were 57 confirmed cases between July and October 2022. Nurseries voluntarily closed to support outbreak control. Subsequent whole genome sequencing identified two separate, unlinked outbreaks of stx 2a-positive E. coli O157:H7 (19 confirmed cases in Nursery 1) and stx- negative E. coli O157:H39 (17 confirmed cases in Nursery 2). Smaller numbers of six additional STEC and E. coli O157 (non-STEC) strains were identified in the four nurseries. Five children from Nursery 1 who tested positive for stx 2a-positive E. coli O157:H7 required hospitalisation, one of whom developed haemolytic uraemic syndrome. Children with other STEC and E. coli O157 (non-STEC) strains had few or no symptoms. Overall, five of 19 cases with s tx 2a subtypes were asymptomatic, compared with seven of nine for stx 2f subtypes, and 14 of 25 for stx -negative subtypes. Given the findings in this setting, further information on the prevalence of asymptomatic STEC carriage by strain, age and geography, and in other contexts, will support understanding and risk management of future outbreaks.


  • Open Access

    Bacteriological Survey of Fresh Minced Beef on Sale at Retail Outlets in Scotland in 2019: Three Foodborne Pathogens, Hygiene Process Indicators, and Phenotypic Antimicrobial Resistance

    by H. Bishop, J. Evans, J. I. Eze, C. Webster, R. W. Humphry, R. Beattie, J. White, J. Couper, L. Allison, D. Brown, et al.

    The health and economic burden of foodborne illness is high, with approximately 2.4 million cases occurring annually in the United Kingdom. A survey to understand the baseline microbial quality and prevalence of food-related hazards of fresh beef mince on retail sale could inform risk assessment, management, and communication to ensure the safety of this commodity. In such a survey, a two-stage sampling design was used to reflect variations in population density and the market share of five categories of retail outlets in Scotland. From January to December 2019, 1,009 fresh minced beef samples were collected from 15 geographic areas. The microbial quality of each sample was assessed using aerobic colony count and Escherichia coli count. Samples were cultured for Campylobacter and Salmonella, and PCR was used to detect target genes (stx1 all variants, stx2 a to g, and rfbO157) for Shiga toxin–producing E. coli (STEC). The presence of viable E. coli O157 and STEC in samples with a positive PCR signal was confirmed via culture and isolation. Phenotypic antimicrobial sensitivity patterns of cultured pathogens and 100 E. coli isolates were determined, mostly via disk diffusion. The median aerobic colony count and E. coli counts were 6.4 × 105 (interquartile range, 6.9 × 104 to 9.6 × 106) and <10 CFU/g (interquartile range, <10 to 10) of minced beef, respectively. The prevalence was 0.1% (95% confidence interval [CI], 0 to 0.7%) for Campylobacter, 0.3% (95% CI, 0 to 1%) for Salmonella, 22% (95% CI, 20 to 25%) for PCR-positive STEC, and 4% (95% CI, 2 to 5%) for culture-positive STEC. The evidence for phenotypic antimicrobial resistance detected did not give cause for concern, mainly occurring in a few E. coli isolates as single nonsusceptibilities to first-line active substances. The low prevalence of pathogens and phenotypic antimicrobial resistance is encouraging, but ongoing consumer food safety education is necessary to mitigate the residual public health risk.HIGHLIGHTSThe prevalence of Campylobacter and Salmonella in fresh minced beef was low.Almost a quarter of samples were PCR positive for Shiga toxin (ST) target genes.A fifth of PCR-positive ST samples were confirmed by isolation of STEC.The risk to consumers from bacterial hazards is mitigated but not negligible.The instruction to thoroughly cook fresh beef mince before eating remains relevant.


  • Open Access

    Epidemiology and genomic analysis of Shiga toxin-producing Escherichia coli clonal complex 165 in the UK

    by Ella V. Rodwell, Bhavita Vishram, Robert Smith, Lynda Browning, Alison Smith-Palmer, Lesley Allison, Anne Holmes, Gauri Godbole, Noel McCarthy, Timothy J. Dallman, et al.

    Introduction. Shiga toxin-producing Escherichia coli (STEC) is a zoonotic, foodborne gastrointestinal pathogen that has the potential to cause severe clinical outcomes, including haemolytic uraemic syndrome (HUS). STEC-HUS is the leading cause of renal failure in children and can be fatal. Over the last decade, STEC clonal complex 165 (CC165) has emerged as a cause of STEC-HUS. Gap Statement. There is a need to understand the pathogenicity and prevalence of this emerging STEC clonal complex in the UK, to facilitate early diagnosis, improve clinical management, and prevent and control outbreaks. Aim. The aim of this study was to characterize CC165 through identification of virulence factors (VFs) and antimicrobial resistance (AMR) determinants in the genome and to integrate the genome data with the available epidemiological data to better understand the incidence and pathogenicity of this clonal complex in the UK. Methodology. All isolates belonging to CC165 in the archives at the UK public health agencies were sequenced and serotyped, and the virulence gene and AMR profiles were derived from the genome using PHE bioinformatics pipelines and the Centre for Genomic Epidemiology virulence database. Results. There were 48 CC165 isolates, of which 43 were STEC, four were enteropathogenic E. coli (EPEC) and one E. coli . STEC serotypes were predominately O80:H2 (n=28), and other serotypes included O45:H2 (n=9), O55:H9 (n=4), O132:H2 (n=1) and O180:H2 (n=1). All but one STEC isolate had Shiga toxin (stx) subtype stx2a or stx2d and 47/48 isolates had the eae gene encoding intimin involved in the intimate attachment of the bacteria to the human gut mucosa. We detected extra-intestinal virulence genes including those associated with iron acquisition (iro) and serum resistance (iss), indicating that this pathogen has the potential to translocate to extra-intestinal sites. Unlike other STEC clonal complexes, a high proportion of isolates (93%, 40/43) were multidrug-resistant, including resistance to aminoglycosides, beta-lactams, chloramphenicol, sulphonamides, tetracyclines and trimethoprim. Conclusion. The clinical significance of this clonal complex should not be underestimated. Exhibiting high levels of AMR and a combination of STEC and extra-intestinal pathogenic E. coli (ExPEC) virulence profiles, this clonal complex is an emerging threat to public health.